What is TECHLAB?
TECHLAB, Inc. operates as a specialized developer and manufacturer of advanced diagnostic products, primarily focused on the detection of intestinal diseases and various foodborne pathogens. The company distinguishes itself through a dual-pronged business model that combines proprietary product innovation with contract manufacturing and research services for industrial and academic partners. With a portfolio that is both ISO certified and FDA registered, TECHLAB provides essential diagnostic tools that enhance laboratory efficiency and clinical outcomes. Their commitment to rigorous quality standards and innovative research has solidified their reputation as a reliable provider of diagnostic solutions for healthcare providers worldwide.
How much funding has TECHLAB raised?
TECHLAB has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in TECHLAB
PPP
Public-Private Partnership
What's next for TECHLAB?
With the infusion of this major strategic investment, TECHLAB is poised to enter a new phase of operational scaling and technological expansion. The company is expected to prioritize the enhancement of its diagnostic pipeline, potentially increasing its market share in the clinical testing sector. Future strategic initiatives will likely focus on optimizing manufacturing throughput and expanding the reach of its FDA-cleared product suite into emerging international markets. By maintaining its focus on high-impact pathogen detection, TECHLAB is strategically aligned to address the growing global demand for rapid, accurate, and efficient diagnostic technologies, ensuring long-term value creation for its stakeholders and the broader medical community.
See full TECHLAB company page
